Avera Pharmaceutical
1
1
0.05
1
- Areas of investment
Summary
Avera Pharmaceutical is the famous Corporate Investor, which was founded in 2002. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Carlsbad.
The higher amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2015.
Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund. Among the most successful fund investment fields, there are Information Technology, Software. For fund there is no match between the location of its establishment and the land of its numerous investments - Finland. Among the various public portfolio startups of the fund, we may underline Bitbar
The typical case for the fund is to invest in rounds with 7 participants. Despite the Avera Pharmaceutical, startups are often financed by Finnvera Venture Capital, Qualcomm Ventures, Draper Esprit. The meaningful sponsors for the fund in investment in the same round are Qualcomm Ventures, Nordic Venture Partners (Sweden), Inventure.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.05
- Investments by industry
- Information Technology (1)
- Software (1)
- Mobile Apps (1)
- Enterprise Software (1)
- Investments by region
-
- Finland (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 26
- Group Appearance index
- 1.00
- Avg. company exit year
- 24
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bitbar | 21 May 2015 | Software, Information Technology, Mobile Apps, Enterprise Software | Early Stage Venture | 0 | Uusimaa, Helsinki, Finland |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.